Inventor · disambiguated record
Yanbin Liang
Also filed as: LIANG YANBIN
13 granted patents·16 pending applications·27 citations·filing 2001–2025
89Inventor score
Top patents by PatentIndex Score
29 records- 0184US7198928B2Human COX-1 alternatively spliced variants and methods of using sameALLERGAN INC·Filed 2003·Granted Apr 3, 2007·11 cites·3 claims
- 0283US2024043518A1Heavy chain only antibodies to pdgfALLERGAN INC·Filed 2023·Application pending·0 cites
- 0382US11028163B2Heavy chain only antibodies to PDGFALLERGAN INC·Filed 2019·Granted Jun 8, 2021·1 cites·8 claims
- 0482US10752678B2Complement component C5 antibodiesALLERGAN INC·Filed 2018·Granted Aug 25, 2020·1 cites·20 claims
- 0581US11046756B2Heavy chain only antibodies to ANG-2ALLERGAN INC·Filed 2019·Granted Jun 29, 2021·1 cites·14 claims
- 0681US10604563B2Nucleic acids encoding anti-complement Factor Bb antibodiesALLERGAN INC·Filed 2018·Granted Mar 31, 2020·1 cites·9 claims
- 0781US9796776B2Complement factor Bb antibodiesALLERGAN INC·Filed 2015·Granted Oct 24, 2017·4 cites·11 claims
- 0881US9701743B2Complement component C5 antibodiesALLERGAN INC·Filed 2015·Granted Jul 11, 2017·3 cites·14 claims
- 0979US10266589B2Heavy chain only antibodies to ANG-2ALLERGAN INC·Filed 2016·Granted Apr 23, 2019·2 cites·6 claims
- 1079US9932395B2Nucleic acids encoding complement component C5 antibodiesALLERGAN INC·Filed 2017·Granted Apr 3, 2018·2 cites·2 claims
- 1176US2023124150A1COMPLEMENT FACTOR Bb ANTIBODIESALLERGAN INC·Filed 2022·Application pending·0 cites
- 1275US10308711B2Heavy chain only antibodies to PDGFALLERGAN INC·Filed 2016·Granted Jun 4, 2019·1 cites·7 claims
- 1375US2025333490A1Heavy chain only antibodies to pdgfALLERGAN INC·Filed 2025·Application pending·0 cites
- 1473US2022098295A1Heavy chain only antibodies to pdgfALLERGAN INC·Filed 2021·Application pending·0 cites
- 1573US2024279317A1Complement component c5 antibodiesALLERGAN INC·Filed 2024·Application pending·0 cites
- 1669US2021324064A1Heavy chain only antibodies to ang-2ALLERGAN INC·Filed 2021·Application pending·0 cites
- 1767US2021101965A1Complement component c5 antibodiesALLERGAN INC·Filed 2020·Application pending·0 cites
- 1866US2020317762A1COMPLEMENT FACTOR Bb ANTIBODIESALLERGAN INC·Filed 2020·Application pending·0 cites
- 1963US2025376535A1Monospecific and multi-specific antibodiesBEIJING STARMAB BIOMED TECH LTD·Filed 2023·Application pending·0 cites
- 2060US10093724B2Methods of treating a complement associated eye condition by administering complement factor Bb antibodiesALLERGAN INC·Filed 2017·Granted Oct 9, 2018·0 cites·20 claims
- 2160US2025304667A1Complement component c5 antibodiesALLERGAN INC·Filed 2025·Application pending·0 cites
- 2254US7612082B2Prostaglandin EP4 antagonistsALLERGAN INC·Filed 2004·Granted Nov 3, 2009·0 cites·2 claims
- 2351US2005084929A1Human prostaglandin EP4 receptor variants and methods of using sameFiled 2003·Application pending·0 cites
- 2451US2005074847A1Human prostaglandin EP1 receptor variants and methods of using sameFiled 2003·Application pending·0 cites
- 2551US2005084931A1Human prostaglandin DP receptor variants and methods of using sameFiled 2003·Application pending·0 cites
- 2650US2023340157A1Monospecific and multi-specific antibodiesBEIJING STARMAB BIOMED TECH LTD·Filed 2020·Application pending·0 cites
- 2749US7320871B2Human prostaglandin FP receptor variants and methods of using sameALLERGAN INC·Filed 2003·Granted Jan 22, 2008·0 cites·10 claims
- 2846US2002177190A1Recombinant simian GPR3 receptorFiled 2001·Application pending·0 cites
- 2940US2013156766A1Treatment of dry age related macular degenerationALLERGAN INC·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yanbin Liang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →